Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
MedMira Inc
MMIRF
Primary Symbol:
V.MIR
Healthcare
Medical Devices
MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely...
the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:MIR)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(44)
•••
CamelHurder
X
View Profile
View Bullboard History
Post by
CamelHurder
on Oct 24, 2022 11:27am
Thanks 4 the memories
waiting fot the 7 year low
(20)
•••
mrmarket1
X
View Profile
View Bullboard History
Post by
mrmarket1
on Oct 24, 2022 6:22am
MAYBE LIZ TRUSS CAN HELP !!
she finished her job in 6 weeks Medmira is taking THIRTY YEARS
GameSquare Sells 25.5% Interest in FaZe Media for $9.5 Million
posted Jun 18, 2024 9:00am by
GameSquare Holdings Inc.
-
|
Justin Kenna, CEO of GameSquare stated, "Today's announcement is a win-win for GameSquare, FaZe Media, and the greater FaZe Clan community. Since completing the acquisition of FaZe Clan in March 2024 our strategy has been focused on reigniting the FaZe brand by returning its founders in a meaningful way. With the support of Matt Kalish and his direct investment in FaZe Media, we structured the new business as a creator-led IP and media company. Today's announcement ...read more
(44)
•••
CamelHurder
X
View Profile
View Bullboard History
Comment by
CamelHurder
on Oct 22, 2022 5:41pm
RE:TOO LONG -TOO SLOW-TOO BAD
MAYBE THE BANK called in their loan---The Bank OF Nova Scotia---- whats the matter with this tempest in a tea pot ***** DUD
(20)
•••
mrmarket1
X
View Profile
View Bullboard History
Post by
mrmarket1
on Oct 20, 2022 10:27am
medmira competitor doubles in price
Dr Chan is promised a medal
(20)
•••
mrmarket1
X
View Profile
View Bullboard History
Post by
mrmarket1
on Oct 20, 2022 10:09am
what achievements
MedMira is thankful to have received support by Rafah DiCostanzo, MLA for Clayton Park West during the pandemic and is grateful for the acknowledgment of the Company's achievement. https://www
...more
(20)
•••
mrmarket1
X
View Profile
View Bullboard History
Post by
mrmarket1
on Oct 20, 2022 10:02am
NS politician enthused with Dr Chan
She is playing the job creation aspect as politicians always do SHE DOESN'T EXPLAIN HERSELF COMPLETELY LIKE MEDMIRA IS ALSO GUILTY OF DOING USUALLY my faith and hope are
...more
(20)
•••
mrmarket1
X
View Profile
View Bullboard History
Post by
mrmarket1
on Oct 18, 2022 6:05pm
TOO LONG -TOO SLOW-TOO BAD
Medmira doesn’t know it’s over —- Medmira will be stifled new companies new technology new science
(3)
•••
kyoung28
X
View Profile
View Bullboard History
Comment by
kyoung28
on Oct 18, 2022 5:28pm
RE:covids future
I know that you’ve been here long enough, and maybe you are right that COVID hasn’t gone yet. My question though is if MM is ever going to be ready for FDA and HC approvals. Neither FDA nor HC don’t
...more
(5)
•••
conservative2
X
View Profile
View Bullboard History
Post by
conservative2
on Oct 15, 2022 9:30pm
covids future
This is a very revealing article. Covid is here to stay and as the population gets complacent about protection, the new variants will jump in and create havoc.' Medmira will thrive
...more
(44)
•••
CamelHurder
X
View Profile
View Bullboard History
Comment by
CamelHurder
on Oct 14, 2022 1:42pm
RE: a complete set of COVID-19 related products.
TD sellers, ------------ Questrade buyers--................-rest are fence sitters
(44)
•••
CamelHurder
X
View Profile
View Bullboard History
Comment by
CamelHurder
on Oct 14, 2022 1:38pm
RE:Medmira will only get HC approval after FDA approval
selloff, ---holders lose faith.... now hope ,---- no I.R. Report
(44)
•••
CamelHurder
X
View Profile
View Bullboard History
Comment by
CamelHurder
on Oct 14, 2022 10:52am
RE:MEDMIRA DYI TOOLS BEFORE SEEING DOCTOR
would like to buy more shares but three others are on a ''roll'
(8)
•••
august202013
X
View Profile
View Bullboard History
Post by
august202013
on Oct 14, 2022 10:46am
MEDMIRA DYI TOOLS BEFORE SEEING DOCTOR
Medmira manufacturer DYI tools of future before deciding to visit the HOSPITAL. Since missed COVID19 TEST KIT PLUS action until next pandemic next best hope could be DYI TOOLS compounded by shortage
...more
(20)
•••
mrmarket1
X
View Profile
View Bullboard History
Post by
mrmarket1
on Oct 14, 2022 7:09am
a complete set of COVID-19 related products.
With the increasing infection rates during the next few months and the need for quality rapid testing solutions, MedMira's VYRA™ COVID-19 is the fastest and most reliable answer. We anticipate our
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 14, 2022 6:01am
New Press Release - MedMira Receives CE Mark for Its VYRA(TM) COVID-19 Antigen Test
HALIFAX, NS / ACCESSWIRE /October 14, 2022 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of the CE mark for its VYRA™ COVID-19 Antigen Test (VYRA™ COVID-19), the fastest SARS-CoV-2 Antigen test available. The Company received the CE mark today and is now available in Europe and...
read article.
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
A Junior Copper-Gold Stock Trading at a Bargain of Monumental Proportions
A Low Cost Natural Gas Producer for Your Portfolio
GameSquare Sells 25.5% Interest in FaZe Media for $9.5 Million